Comparative Study on Diagnosis Value of Contrast-Enhanced Ultrasound and Contrast-Enhanced Computed Tomography after Treating Advanced Renal Cancer Patients with Yiqi Jiedu Decoction

Table 1

Statistics of patients’ general information of the two groups (n = 30).

Observation indicator	Control group	Study group	t/X^2
Age (years)	50.48 ± 8.36	51.13 ± 8.52	0.298	0.767
Tumor diameter (cm)	3.51 ± 2.23	3.47 ± 2.31	0.068	0.946
Gender (male)	11 (36.67%)	13 (43.33%)	0.278	0.596
Affected side			0.268	0.605
Left	17 (56.67%)	15 (50%)
Right	13 (43.33%)	15 (50%)
Tumor position
Upper pole of the kidney	7 (23.33%)	6 (20%)	0.098	0.754
Midpole of the kidney	12 (40%)	14 (46.67%)	0.272	0.602
Lower pole of the kidney	11 (36.67%)	10 (33.33%)	0.073	0.787
Clinical manifestation
Painless hematuria	11 (36.67%)	9 (30%)	0.300	0.584
Lumbago	4 (13.33%)	5 (16.67%)	0.131	0.718
Hematuria with lumbago	15 (50%)	16 (53.33%)	0.067	0.796
Pathological type			0.341	0.559
Locally advanced renal cell carcinoma	23 (76.67%)	21 (70%)
Metastatic renal cell carcinoma	7 (23.33%)	9 (30%)